Central Centrifugal Cicatricial Alopecia (CCCA): Unraveling the Complexities of a Scarring Hair Disorder

Main Article Content

Giovanna Aldonza Rios López
Gladys Montserrat Ballesteros Solís

Abstract

Central Centrifugal Cicatricial Alopecia (CCCA) represents a distinct form of scarring alopecia predominantly affecting individuals of African descent. This article provides an in-depth examination of the clinical characteristics, pathogenesis, diagnostic challenges, and evolving therapeutic strategies associated with CCCA. By synthesizing current research findings, we aim to enhance awareness, facilitate early diagnosis, and explore emerging interventions for this enigmatic hair disorder. A comprehensive understanding of CCCA is essential for clinicians to optimize patient care and contribute to ongoing efforts in advancing the field of trichology.

Article Details

How to Cite
Giovanna Aldonza Rios López, & Gladys Montserrat Ballesteros Solís. (2024). Central Centrifugal Cicatricial Alopecia (CCCA): Unraveling the Complexities of a Scarring Hair Disorder. International Journal of Medical Science and Clinical Research Studies, 4(02), 286–289. https://doi.org/10.47191/ijmscrs/v4-i02-21
Section
Articles

References

I. Flamm A, Moshiri AS, Roche F, Onyekaba G, Nguyen J, James AJ, Taylor S, Seykora JT. Characterization of the inflammatory features of central centrifugal cicatricial alopecia. J Cutan Pathol. 2020 Jun;47(6):530-534.

II. Aguh C. Updates in our understanding of central centrifugal cicatricial alopecia. Cutis. 2019 Dec;104(6):316;340

III. Araoye EF, Thomas JAL, Aguh CU. Hair regrowth in 2 patients with recalcitrant central centrifugal cicatricial alopecia after use of topical metformin. JAAD Case Rep. 2020 Feb;6(2):106-108.

IV. Sundberg JP, Hordinsky MK, Bergfeld W, Lenzy YM, McMichael AJ, Christiano AM, McGregor T, Stenn KS, Sivamani RK, Pratt CH, King LE. Cicatricial Alopecia Research Foundation meeting, May 2016: Progress towards the diagnosis, treatment and cure of primary cicatricial alopecias. Exp Dermatol. 2018 Mar;27(3):302-310.

V. Malki L, Sarig O, Romano MT, Méchin MC, Peled A, Pavlovsky M, Warshauer E, Samuelov L, Uwakwe L, Briskin V, Mohamad J, Gat A, Isakov O, Rabinowitz T, Shomron N, Adir N, Simon M, McMichael A, Dlova NC, Betz RC, Sprecher E. Variant PADI3 in Central Centrifugal Cicatricial Alopecia. N Engl J Med. 2019 Feb 28;380(9):833-841.

VI. Anzai A, Wang EHC, Lee EY, Aoki V, Christiano AM. Pathomechanisms of immune-mediated alopecia. Int Immunol. 2019 Jul 13;31(7):439-447.

VII. Akintilo L, Hahn EA, Yu JMA, Patterson SSL. Health care barriers and quality of life in central centrifugal cicatricial alopecia patients. Cutis. 2018 Dec;102(6):427-432.

VIII. Haskin A, Aguh C, Okoye GA. Understanding patient experiences with scarring alopecia: a qualitative study with management implications. J Dermatolog Treat. 2017 Jun;28(4):318-321.

IX. Fernandez-Flores A. Use of Giemsa staining in the evaluation of central centrifugal cicatricial alopecia. J Cutan Pathol. 2020 May;47(5):496-499.

X. Miteva M, Tosti A. Central Centrifugal Cicatricial Alopecia Presenting with Irregular Patchy Alopecia on the Lateral and Posterior Scalp. Skin Appendage Disord. 2015 Mar;1(1):1-5.

XI. Griggs J, Trüeb RM, Gavazzoni Dias MFR, Hordinsky M, Tosti A. Fibrosing alopecia in a pattern distribution. J Am Acad Dermatol. 2021 Dec;85(6):1557-1564.

XII. Su HJ, Cheng AY, Liu CH, Chu CB, Lee CN, Hsu CK, Lee JY, Yang CC. Primary scarring alopecia: A retrospective study of 89 patients in Taiwan. J Dermatol. 2018 Apr;45(4):450-455.

Most read articles by the same author(s)